KANG [iKang Healthcare] DRSLTR: New York Menlo Park Washington DC São Paulo

[New York Menlo Park Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Li He LLP Davis Polk & Wardwell 2201 China World Office 2 1 Jian Guo Men Wai Avenue Chaoyang District Beijing 100004 86 10 8567 5005 tel 86 10 8567 5105 fax li.he@davispolk.com February 14, 2014 iKang Guobin Healthcare Group, Inc. Draft Registration Statement on]

GOMO [Sungy Mobile] SC 13G: Joint Filing Agreement Xiangdong Zhang Xiangdong Zhang Director

[Joint Filing Agreement Xiangdong Zhang Xiangdong Zhang Director Hamamelis Holdings Limited Xiangdong Zhang Director EX-99.1 2 d680081dex991.htm EX-99.1] [CUSIP No. 86737M 100 1 Names of reporting persons Xiangdong Zhang 2 Check the appropriate box if a member of a group ¨ (a) ¨ (b) 3 SEC use only 4 Citizenship or place of organization People’s Republic of China Number of shares beneficially owned by each reporting person with: 5 Sole voting power (1) 14,900,039 ordinary shares]

By | 2016-03-18T20:03:54+00:00 February 14th, 2014|Categories: Chinese Stocks, GOMO, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2013 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1213ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q1213ex32ii_tianyinphar.htm CERTIFICATION]

By | 2016-03-19T16:00:54+00:00 February 14th, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CCCL [China Ceramics] SC 13G: JOINT FILING AGREEMENT Prescott Group Capital Management, L.L.C.

[JOINT FILING AGREEMENT Prescott Group Capital Management, L.L.C. PHIL FROHLICH, Managing Member Prescott Group Aggressive Small Cap, L.P. PHIL FROHLICH, Managing Member 1 Prescott Group Aggressive Small Cap II, L.P. PHIL FROHLICH, Managing Member Phil Frohlich 2 EX-99.1 2 d674982dex991.htm EX-99.1] [CUSIP No. G2113X100 13G 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Prescott Group Capital Management, L.L.C. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Oklahoma NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5]

By | 2016-03-14T21:19:57+00:00 February 14th, 2014|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

TSL [Trina Solar] SC 13G/A: [*] The title of the securities underlying the

[[*] The title of the securities underlying the American Depositary Shares is ordinary shares. The CUSIP reported is the CUSIP for the American Depositary Shares. Each American Depositary Share represents 50 ordinary shares. The securities covered by this Schedule 13G/A may include ordinary shares and American Depositary Shares. CUSIP NO. 89628E104 13G/A Page 2 of 10 Pages 1. NAME OF]

By | 2016-03-11T02:11:18+00:00 February 14th, 2014|Categories: Chinese Stocks, TSL, Webplus ver|Tags: , , , , , |0 Comments

GOMO [Sungy Mobile] SC 13G: Joint Filing Agreement Yuqiang Deng Yuqiang Deng Freedom

[Joint Filing Agreement Yuqiang Deng Yuqiang Deng Freedom First Holdings Limited Yuqiang Deng Director EX-99.1 2 d680078dex991.htm EX-99.1] [CUSIP No. 86737M 100 1 Names of reporting persons Yuqiang Deng 2 Check the appropriate box if a member of a group ¨ (a) ¨ (b) 3 SEC use only 4 Citizenship or place of organization People’s Republic of China Number of shares beneficially owned by each reporting person with: 5 Sole voting power (1) 45,909,710 ordinary shares]

By | 2016-03-18T20:06:25+00:00 February 14th, 2014|Categories: Chinese Stocks, GOMO, Webplus ver|Tags: , , , , , |0 Comments

CBAK [CHINA BAK BATTERY] NT 10-Q: FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ For Period Ended: December 31, 2013 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to]

WUBA [58.com] SC 13G: JOINT FILING AGREEMENT ——————————— Dated: February 14, 2014

[JOINT FILING AGREEMENT --------------------------------- Dated: February 14, 2014 Dated: February 14, 2014 WP X ASIA ONLINE INVESTMENT HOLDINGS LIMITED WARBURG PINCUS PRIVATE EQUITY X, L.P. Warburg Pincus X, L.P., its general partner Warburg Pincus X LLC, its general partner Warburg Pincus Partners LLC, its sole member Warburg Pincus & Co., its managing member] [SCHEDULE 13G 58.com Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.00001 per share (Title of Class of Securities) 31680Q104† (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject]

KANG [iKang Healthcare] DRS/A: CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP,

[CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP, INC. SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Guobin Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Guobin Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee th st Address: 701, 7 Party B: ID Number: 320102198102151619 Party C: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose of this Agreement, the Pledgee, Pledgors and Party C are individually referred to as “ Whereas:] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated February 14, 2014 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc. its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]

Skip to toolbar